Throughout the time developing stem cell medicine, Gwo Xi Stem Cell Company has established platforms spanning entire industry chain, including clinical grade stem cell preparation platform, clinical grade cell storage platform, clinical grade cell product testing platform.

So far, these platforms have served several domestic cell therapy developers and hospitals. These technologies are based on our core values: Innovation, Proficiency, and Responsibility. Each platform is fully compliant with the medical regulation in Taiwan. Furthermore, with self-demanding spirit, we constantly maintain our services' quality by subcontracting the third party to examine our platforms annually. In addition, we have signed several agreements with domestic hospitals and clinics to apply stem cell therapy through special reguation in Taiwan, and we have also assisted 4 clinics in getting approval (100%) from Joint Commission of Taiwan so that the clinics can legally apply cell therapy in the future. To befit our customers' expectation, we are commited to improving our technologies and providing more complete service in the future.

．Adopting automatic equipments
．Plentiful experience executing cell therapy clinical trial
．Four stem cell therapy medicines are ongoing in clinical trial
．Modular production design can fit the expectation from customers
．Services span the entire cell therapy industry chain
．Excuting cell therapy clinical trial overseas and managing the cold chain transport for allogeneic stem cells delivery